Clinical Trial Update: Propel Drug-Eluting Sinus Implant Family IBUKI Cohort

View source ↗

Summary

Medtronic reports a clinical trial update for the Propel Drug-Eluting Sinus Implant (IBUKI Family) cohort. The study is currently recruiting participants with c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rhinosinusitis

Drugs mentioned

• Propel Drug-Eluting Sinus Implant (IBUKI Family)

Snippet

Sponsor: Medtronic | Conditions: Chronic Rhinosinusitis (CRS) | Status: RECRUITING